Cancer stem cells (CSCs), firstly presented in 1997, when only CD34+CD38− gave rise to patients with acute myeloid leukemia (AML) in nonobese diabetic/severe combined with immunodeficient mice, could induce hematopoietic malignancies demonstrated by Bonnet and Dick [6]. Here, CD34 is linked to acute myeloid leukemia.